Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 17.

Journal Article

Berghoff, Anna S., Bellosillo, Beatriz, Caux, Christophe ORCID: 0000-0003-2438-833X, de Langen, Adrianus, Mazieres, Julien, Normanno, Nicola ORCID: 0000-0002-7158-2605, Preusser, Matthias, Provencio, Mariano, Rojo, Federico, Wolf, Jurgen and Zielinski, Christoph C. (2019). Immune checkpoint inhibitor treatment in patients with oncogene-addicted non-small cell lung cancer (NSCLC): summary of a multidisciplinary roundtable discussion. ESMO Open, 4 (3). LONDON: BMJ PUBLISHING GROUP. ISSN 2059-7029

Bianco, Julien N., Bergoglio, Valerie, Lin, Yea-Lih, Pillaire, Marie-Jeanne ORCID: 0000-0001-6866-7416, Schmitz, Anne-Lyne, Gilhodes, Julia, Lusque, Amelie, Mazieres, Julien, Lacroix-Triki, Magali, Roumeliotis, Theodoros, I, Choudhary, Jyoti, Moreaux, Jerome ORCID: 0000-0002-5717-3207, Hoffmann, Jean-Sebastien ORCID: 0000-0003-2222-354X, Tourriere, Helene and Pasero, Philippe ORCID: 0000-0001-5891-0822 (2019). Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner. Nat. Commun., 10. LONDON: NATURE PUBLISHING GROUP. ISSN 2041-1723

Drilon, Alexander, Lin, Jessica J., Filleron, Thomas, Ni, Ai ORCID: 0000-0003-3002-3556, Milia, Julie, Bergagnini, Isabella, Hatzoglou, Vaios, Velcheti, Vamsidhar, Offin, Michael, Li, Bob, Carbone, David P., Besse, Benjamin ORCID: 0000-0001-5090-8189, Mok, Tony, Awad, Mark M., Wolf, Jurgen, Owen, Dwight ORCID: 0000-0002-6598-4886, Camidge, D. Ross, Riely, Gregory J., Peled, Nir, Kris, Mark G., Mazieres, Julien, Gainor, Justin F. and Gautschi, Oliver (2018). Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers. J. Thorac. Oncol., 13 (10). S. 1595 - 1602. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

Drilon, Alexander E., Filleron, Thomas, Bergagnini, Isabella, Milia, Julie, Hatzoglou, Vaios, Velcheti, Vamsidhar, Besse, Benjamin ORCID: 0000-0001-5090-8189, Mok, Tony, Awad, Mark M., Wolf, Juergen, Carbone, David P., Camidge, D. Ross, Riely, Gregory J., Peled, Nir, Mazieres, Julien, Kris, Mark G. and Gautschi, Oliver (2017). Baseline frequency of brain metastases and outcomes with multikinase inhibitor therapy in patients with RET-rearranged lung cancers. J. Clin. Oncol., 35. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Gautschi, Oliver, Milia, Julie, Cabarrou, Bastien, Bluthgen, Marie-Virginia, Besse, Benjamin ORCID: 0000-0001-5090-8189, Smit, Egbert F., Wolf, Juergen, Peters, Solange, Frueh, Martin, Koeberle, Dieter, Oulkhouir, Youssouf, Schuler, Martin, Curioni-Fontecedro, Alessandra, Huret, Benjamin, Kerjouan, Mallorie, Michels, Sebastian, Pall, Georg, Rothschild, Sacha ORCID: 0000-0003-1304-9340, Schmid-Bindert, Gerald, Scheffler, Matthias ORCID: 0000-0002-9031-1368, Veillon, Remi, Wannesson, Luciano, Diebold, Joachim, Zalcman, Gerard, Filleron, Thomas and Mazieres, Julien (2015). Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort. J. Thorac. Oncol., 10 (10). S. 1451 - 1458. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

Gautschi, Oliver, Milia, Julie, Filleron, Thomas, Wolf, Juergen, Carbone, David P., Owen, Dwight ORCID: 0000-0002-6598-4886, Camidge, Ross, Narayanan, Vignhesh, Doebele, Robert C. ORCID: 0000-0001-6728-6857, Besse, Benjamin ORCID: 0000-0001-5090-8189, Remon-Masip, Jordi, Janne, Pasi A., Awad, Mark M., Peled, Nir, Byoung, Chul-Cho, Karp, Daniel D., Van Den Heuvel, Michael, Wakelee, Heather A., Neal, Joel W., Mok, Tony S. K., Yang, James C. H., Ou, Sai-Hong Ignatius, Pall, Georg, Froesch, Patrizia, Zalcman, Gerard, Gandara, David R., Riess, JonathanW., Velcheti, Vamsidhar, Zeidler, Kristin, Diebold, Joachim, Frueh, Martin, Michels, Sebastian, Monnet, Isabelle, Popat, Sanjay ORCID: 0000-0003-2087-4963, Rosell, Rafael, Karachaliou, Niki, Rothschild, Sacha I., Shih, Jin-Yuan, Warth, Arne, Muley, Thomas, Cabillic, Florian ORCID: 0000-0001-7204-5652, Mazieres, Julien and Drilon, Alexander (2017). Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry. J. Clin. Oncol., 35 (13). S. 1403 - 1414. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Gautschi, Oliver, Milia-Baron, Julie, Filleron, Thomas, Wolf, Juergen, Carbone, David, Owen, Dwight, Camidge, D. Ross, Narayanan, Vighesh, Doebele, Robert, Besse, Benjamin ORCID: 0000-0001-5090-8189, Remon, Jordi, Janne, Pasi, Awad, Mark, Peled, Nir, Byoung, Chul-Cho, Karp, Daniel, Van den Heuve, Michael, Wakelee, Heather, Nea, Joel, Mok, Tony, Yang, James Chih-Hsin, Ou, Sai-Hong, Pa, Georg, Froesch, Patrizia, Zalcman, Gerard, Gandara, David R., Riess, Jonathan, Velcheti, Vamsidhar, Zeidler, Kristin, Diebold, Joachim, Fruh, Martin, Michels, Sebastian, Monnet, Isabelle, Popat, Sanjay ORCID: 0000-0003-2087-4963, Rosell, Rafael, Karachaliou, Niki, Rothschild, Sacha ORCID: 0000-0003-1304-9340, Shih, Jin-Yuan, Warth, Arne, Muley, Thomas, Cabillic, Florian ORCID: 0000-0001-7204-5652, Mazieres, Julien and Drilon, Alexander (2017). Global RET Registry (GLORY): Activity of RET-Directed Targeted Therapies in RET-Rearranged Lung Cancers. J. Thorac. Oncol., 12 (1). S. S435 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

Gautschi, Oliver, Wolf, Juergen, Milia, Julie, Filleron, Thomas, Carbone, David Paul, Camidge, D. Ross, Shih, Jin-Yuan, Awad, Mark M., Cabillic, Florian ORCID: 0000-0001-7204-5652, Peled, Nir, Van Den Heuvel, Michel, Owen, Dwight Hall, Kris, Mark G., Janne, Pasi A., Besse, Benjamin ORCID: 0000-0001-5090-8189, Cho, Byoung Chul, Karp, Daniel D., Rosell, Rafael, Mazieres, Julien and Drilon, Alexander E. (2016). Targeting RET in patients with RET-rearranged lung cancers: Results from a global registry. J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Horn, Leora, Rizvi, Naiyer, Mazieres, Julien, Planchard, David, Stinchcombe, Thomas E., Dy, Grace K., Antonia, Scott J., Lena, Herve, Minenza, Elisa, Mennecier, Bertrand, Otterson, Gregory A., Campos, Luis T., Gandara, David R., Levy, Benjamin P., Nair, Suresh G., Zalman, Gerard, Wolf, Juergen, Paik, Paul, Zhu, Jin, Xu, Dong, Neely, Jaclyn, Qi, Zenhao, Harbison, Christopher T., Lynch, Mark and Ramalingam, Suresh S. (2015). LONGER-TERM FOLLOW-UP OF A PHASE 2 STUDY (CHECKMATE 063) OF NIVOLUMAB IN PATIENTS WITH ADVANCED REFRACTORY SQUAMOUS (SQ) NON-SMALL CELL LUNG CANCER (NSCLC). Asia-Pac. J. Clin. Oncol., 11. S. 124 - 125. HOBOKEN: WILEY-BLACKWELL. ISSN 1743-7563

Horn, Leora, Rizvi, Naiyer A., Mazieres, Julien, Planchard, David, Stinchcombe, Thomas E., Dy, Grace K., Antonia, Scott J., Lena, Herve, Minenza, Elisa, Mennecier, Bertrand, Otterson, Gregory A., Campos, Luis T., Gandara, David R., Levy, Benjamin P., Nair, Suresh G., Zalcman, Gerard, Wolf, Juergen, Paik, Paul, Li, Ang, Xu, Dong, Neely, Jaclyn, Qi, Zhenhao, Harbison, Christopher, Lynch, Mark and Ramalingam, Suresh S. (2015). Longer-Term Follow-Up of a Phase 2 Study (CheckMate 063) of Nivolumab in Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer. J. Thorac. Oncol., 10 (9). S. S175 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

Janne, Pasi, Van den Heuvel, Michel, Barlesi, Fabrice, Cobo, Manuel, Mazieres, Julien, Crino, Lucio, Orlov, Sergey, Blackhall, Fiona, Wolf, Juergen, Garrido, Pilar, Mariani, Gabriella, Poltoratskiy, Artem, Ghiorghiu, Dana, Mckeown, Astrid, Kilgour, Elaine, Angell, Helen, Smith, Paul, Kohlmann, Alexander, Lawrence, David, Bowen, Karin and Vansteenkiste, Johan (2017). Impact of PD-L1 Status on Clinical Response in SELECT-1: Selumetinib plus Docetaxel in KRASm Advanced NSCLC. J. Thorac. Oncol., 12 (1). S. S952 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

Janne, Pasi A., van den Heuvel, Michel M., Barlesi, Fabrice, Cobo, Manuel, Mazieres, Julien, Crino, Lucio, Orlov, Sergey ORCID: 0000-0001-6080-8042, Blackhall, Fiona ORCID: 0000-0001-8716-3395, Wolf, Juergen, Garrido, Pilar, Poltoratskiy, Artem, Mariani, Gabriella, Ghiorghiu, Dana, Kilgour, Elaine, Smith, Paul, Kohlmann, Alexander, Carlile, David J., Lawrence, David, Bowen, Karin and Vansteenkiste, Johan (2017). Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer The SELECT-1 Randomized Clinical Trial. JAMA-J. Am. Med. Assoc., 317 (18). S. 1844 - 1854. CHICAGO: AMER MEDICAL ASSOC. ISSN 1538-3598

Mazieres, Julien, Zalcman, Gerard, Crino, Lucio, Biondani, Pamela, Barlesi, Fabrice, Filleron, Thomas, Dingemans, Anne-Marie C., Lena, Herve, Monnet, Isabelle, Rothschild, Sacha I., Cappuzzo, Federico, Besse, Benjamin ORCID: 0000-0001-5090-8189, Thiberville, Luc, Rouviere, Damien, Dziadziuszko, Rafal ORCID: 0000-0001-8080-9843, Smit, Egbert F., Wolf, Jurgen, Spirig, Christian, Pecuchet, Nicolas ORCID: 0000-0002-3321-5791, Leenders, Frauke, Heuckmann, Johannes M., Diebold, Joachim, Milia, Julie D., Thomas, Roman K. and Gautschi, Oliver (2015). Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort. J. Clin. Oncol., 33 (9). S. 992 - 1002. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Mazieres, Julien, Zalcman, Gerard, Crino, Lucio, Biondani, Pamela, Barlesi, Fabrice, Filleron, Thomas, Dingemans, Anne-Marie C., Lena, Herve, Monnet, Isabelle, Rothschild, Sacha I., Cappuzzo, Federico, Besse, Benjamin ORCID: 0000-0001-5090-8189, Thiberville, Luc, Rouviere, Damien, Dziadziuszko, Rafal ORCID: 0000-0001-8080-9843, Smit, Egbert F., Wolf, Jurgen, Spirig, Christian, Pecuchet, Nicolas ORCID: 0000-0002-3321-5791, Leenders, Frauke, Heuckmann, Johannes M., Diebold, Joachim, Milia, Julie D., Thomas, Roman K. and Gautschi, Oliver (2015). Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort. J. Clin. Oncol., 33 (9). S. 992 - 1002. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Mazieres, Julien, Zalcman, Gerard, Crino, Lucio, Biondani, Pamela, Besse, Benjamin ORCID: 0000-0001-5090-8189, Dingemans, Anne-Marie C., Lena, Herve, Monnet, Isabelle, Rothschild, Sacha ORCID: 0000-0003-1304-9340, Cappuzzo, Federico, Thiberville, Luc, Rouviere, Damien, Dziadziuszko, Rafal ORCID: 0000-0001-8080-9843, Smit, Egbert F., Wolf, Juergen, Spirig, Christian, Pecuchet, Nicolas, Diebold, Joachim, Milia, Julie and Gautschi, Oliver (2014). Efficacy of crizotinib in ROSI-rearranged lung cancer: The European experience. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Rizvi, Naiyer A., Mazieres, Julien, Planchard, David, Stinchcombe, Thomas E., Dy, Grace K., Antonia, Scott J., Horn, Leora, Lena, Herve, Minenza, Elisa, Mennecier, Bertrand, Otterson, Gregory A., Campos, Luis T., Gandara, David R., Levy, Benjamin P., Nair, Suresh G., Zalcman, Gerard, Wolf, Juergen, Souquet, Pierre-Jean, Baldini, Editta, Cappuzzo, Federico, Chouaid, Christos, Dowlati, Afshin, Sanborn, Rachel, Lopez-Chavez, Ariel, Grohe, Christian, Huber, Rudolf M. ORCID: 0000-0001-7041-6368, Harbison, Christopher T., Baudelet, Christine, Lestini, Brian J. and Ramalingam, Suresh S. (2015). Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Lancet Oncol., 16 (3). S. 257 - 266. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Rizvi, Naiyer A., Mazieres, Julien, Planchard, David, Stinchcombe, Thomas E., Dy, Grace K., Antonia, Scott J., Horn, Leora, Lena, Herve, Minenza, Elisa, Mennecier, Bertrand, Otterson, Gregory A., Campos, Luis T., Gandara, David R., Levy, Benjamin P., Nair, Suresh G., Zalcman, Gerard, Wolf, Juergen, Souquet, Pierre-Jean, Baldini, Editta, Cappuzzo, Federico, Chouaid, Christos, Dowlati, Afshin, Sanborn, Rachel, Lopez-Chavez, Ariel, Grohe, Christian, Huber, Rudolf M. ORCID: 0000-0001-7041-6368, Harbison, Christopher T., Baudelet, Christine, Lestini, Brian J. and Ramalingam, Suresh S. (2015). Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Lancet Oncol., 16 (3). S. 257 - 266. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

This list was generated on Wed Oct 27 02:53:14 2021 CEST.